Skip to content

Clinical trials

Observational Retinal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Diseases Phase: Observational Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20031
20043
20051
20073
20084
20091
20103
20114
20126
20133
20146
20154
20166
20177
20185
20194
20208
20218
20229
202312
20243
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Unknown status23
Recruiting17
Active, not recruiting9
Terminated6
Not yet recruiting4
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)11
Bayer4
Beijing Tongren Hospital3
Insel Gruppe AG, University Hospital Bern3
Sun Yat-sen University3
Adverum Biotechnologies, Inc.2
Association for Innovation and Biomedical Research on Light and Image2
Duke University2
Nanoscope Therapeutics Inc.2
National Institute of Neurological Disorders and Stroke (NINDS)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Diseases118
Diabetic Retinopathy24
Macular Degeneration20
Diabetes Mellitus17
Eye Diseases15
Glaucoma14
Retinal Degeneration9
Retinitis Pigmentosa9
Corneal Diseases8
Choroid Diseases6

Trials

Showing 51 to 75 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.